From: A 1,408 km bicycle tour with prostate cancer patients—results of a pilot study
Subject | Age | Weight (kg) | Height (cm) | BMI (kg/m2) | Diagnosis |
---|---|---|---|---|---|
1 | 67 | 86 | 182 | 25.96 | Prostate cancer; p T2c; G2; Gleasen score, 3 + 3 = 6 |
2 | 67 | 95 | 185 | 27.76 | Adenocarcinoma of the prostate pT3b; pN0 (0/23); cM0; G3; Gleason score, 4 + 4 = 8 |
3 | 69 | 93 | 173 | 31.07 | Prostate cancer pT2c; pN0; pR1; G2; Gleason score, 3 + 3 = 6 |
4 | 66 | 80 | 185 | 23.37 | Prostate cancer T2c; pN0; Gleason score, 3 + 4 = 7 |
5 | 66 | 82 | 176 | 26.47 | Prostate cancer pT3b; pN0 (0/6); R0; G2b; Gleason score, 4 + 3 = 7 |
6 | 66 | 87 | 182 | 26.26 | Adenocarcinoma of the prostate pT2b; pN0 (0/3); pMX; pL0; pV0; pR0; Gleason score, 3 + 4 = 7 |
7 | 65 | 87 | 178 | 27.46 | Prostate cancer T2c; N0; M0; G3; Gleason score, 5 + 5 = 10 |
8 | 69 | 94 | 182 | 28.38 | Prostate cancer G2a; Gleason score, 3 + 3 = 6 |